Related Experiment Videos
Pathology of diffuse malignant pleural mesothelioma
1The Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
Seminars in Thoracic and Cardiovascular Surgery
|November 14, 1997
Summary
Accurate diagnosis of malignant pleural mesothelioma requires pathological examination. Immunohistochemistry aids in distinguishing mesothelioma from mimics, but challenges remain, with cytogenetics offering future diagnostic potential.
Area of Science:
- Pathology
- Oncology
Background:
- Accurate diagnosis of diffuse malignant pleural mesothelioma is crucial for effective treatment.
- Pathological examination with special techniques is generally required for diagnosis.
- Immunohistochemistry has improved mesothelioma diagnosis but challenges persist due to mimicry by reactive hyperplasias and tumors.
Purpose of the Study:
- To review diagnostic techniques for diffuse malignant pleural mesothelioma.
- To highlight the role of immunohistochemistry in differentiating mesothelioma from mimics.
- To discuss ongoing challenges and future directions in mesothelioma diagnosis.
Main Methods:
- Review of pathological examination techniques, including conventional histology, histochemistry, electron microscopy, and immunohistochemistry.
- Discussion of morphological examination for distinguishing mesothelioma from reactive mesothelial proliferations.
- Mention of recent cytogenetic studies in mesothelioma.
Main Results:
- Mesotheliomas are classified into epithelial, mixed, sarcomatoid, and undifferentiated types, providing prognostic information.
- Immunohistochemistry is effective in distinguishing epithelial mesothelioma from metastatic adenocarcinoma and sarcomatoid mesothelioma from its mimics.
- Distinguishing mesothelioma from reactive mesothelial proliferations remains challenging based on morphology alone.
Conclusions:
- While immunohistochemistry is a valuable tool, diagnostic difficulties in mesothelioma persist.
- Morphological examination remains critical, especially for differentiating mesothelioma from reactive proliferations.
- Cytogenetic studies show promise for future diagnostic assistance in mesothelioma.